Advanced

Global cancer surgery: delivering safe, affordable, and timely cancer surgery

Sullivan, Richard; Alatise, Olusegun Isaac; Anderson, Benjamin O.; Audisio, Riccardo; Autier, Philippe; Aggarwal, Ajay; Balch, Charles; Brennan, Murray F.; Dare, Anna and D'Cruz, Anil, et al. (2015) In The Lancet Oncology 16(11). p.1193-1224
Abstract
Surgery is essential for global cancer care in all resource settings. Of the 15.2 million new cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, we estimate that annually 45 million surgical procedures will be needed worldwide. Yet, less than 25% of patients with cancer worldwide actually get safe, aff ordable, or timely surgery. This Commission on global cancer surgery, building on Global Surgery 2030, has examined the state of global cancer surgery through an analysis of the burden of surgical disease and breadth of cancer surgery, economics and fi nancing, factors for strengthening surgical systems for cancer with multiple-country studies, the research agenda, and the political factors that frame... (More)
Surgery is essential for global cancer care in all resource settings. Of the 15.2 million new cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, we estimate that annually 45 million surgical procedures will be needed worldwide. Yet, less than 25% of patients with cancer worldwide actually get safe, aff ordable, or timely surgery. This Commission on global cancer surgery, building on Global Surgery 2030, has examined the state of global cancer surgery through an analysis of the burden of surgical disease and breadth of cancer surgery, economics and fi nancing, factors for strengthening surgical systems for cancer with multiple-country studies, the research agenda, and the political factors that frame policy making in this area. We found wide equity and economic gaps in global cancer surgery. Many patients throughout the world do not have access to cancer surgery, and the failure to train more cancer surgeons and strengthen systems could result in as much as US$ 6.2 trillion in lost cumulative gross domestic product by 2030. Many of the key adjunct treatment modalities for cancer surgery-eg, pathology and imaging-are also inadequate. Our analysis identifi ed substantial issues, but also highlights solutions and innovations. Issues of access, a paucity of investment in public surgical systems, low investment in research, and training and education gaps are remarkably widespread. Solutions include better regulated public systems, international partnerships, super-centralisation of surgical services, novel surgical clinical trials, and new approaches to improve quality and scale up cancer surgical systems through education and training. Our key messages are directed at many global stakeholders, but the central message is that to deliver safe, aff ordable, and timely cancer surgery to all, surgery must be at the heart of global and national cancer control planning. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
The Lancet Oncology
volume
16
issue
11
pages
1193 - 1224
publisher
Elsevier
external identifiers
  • wos:000361875200006
  • scopus:84942586191
  • pmid:26427363
ISSN
1474-5488
DOI
10.1016/S1470-2045(15)00223-5
language
English
LU publication?
yes
id
e5c1b5a7-e0e0-4463-87c8-bbc2439dfa19 (old id 8070934)
date added to LUP
2015-10-22 07:56:21
date last changed
2017-11-19 03:04:07
@article{e5c1b5a7-e0e0-4463-87c8-bbc2439dfa19,
  abstract     = {Surgery is essential for global cancer care in all resource settings. Of the 15.2 million new cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, we estimate that annually 45 million surgical procedures will be needed worldwide. Yet, less than 25% of patients with cancer worldwide actually get safe, aff ordable, or timely surgery. This Commission on global cancer surgery, building on Global Surgery 2030, has examined the state of global cancer surgery through an analysis of the burden of surgical disease and breadth of cancer surgery, economics and fi nancing, factors for strengthening surgical systems for cancer with multiple-country studies, the research agenda, and the political factors that frame policy making in this area. We found wide equity and economic gaps in global cancer surgery. Many patients throughout the world do not have access to cancer surgery, and the failure to train more cancer surgeons and strengthen systems could result in as much as US$ 6.2 trillion in lost cumulative gross domestic product by 2030. Many of the key adjunct treatment modalities for cancer surgery-eg, pathology and imaging-are also inadequate. Our analysis identifi ed substantial issues, but also highlights solutions and innovations. Issues of access, a paucity of investment in public surgical systems, low investment in research, and training and education gaps are remarkably widespread. Solutions include better regulated public systems, international partnerships, super-centralisation of surgical services, novel surgical clinical trials, and new approaches to improve quality and scale up cancer surgical systems through education and training. Our key messages are directed at many global stakeholders, but the central message is that to deliver safe, aff ordable, and timely cancer surgery to all, surgery must be at the heart of global and national cancer control planning.},
  author       = {Sullivan, Richard and Alatise, Olusegun Isaac and Anderson, Benjamin O. and Audisio, Riccardo and Autier, Philippe and Aggarwal, Ajay and Balch, Charles and Brennan, Murray F. and Dare, Anna and D'Cruz, Anil and Eggermont, Alexander M. M. and Fleming, Kenneth and Gueye, Serigne Magueye and Hagander, Lars and Herrera, Cristian A. and Holmer, Hampus and Ilbawi, Andre and Jarnheimer, Anton and Ji, Jia-fu and Kingham, T. Peter and Liberman, Jonathan and Leather, Andrew J. M. and Meara, John G. and Mukhopadhyay, Swagoto and Murthy, Shilpa S. and Omar, Sherif and Parham, Groesbeck P. and Pramesh, C. S. and Riviello, Robert and Rodin, Danielle and Santini, Luiz and Shrikhande, Shailesh V. and Shrime, Mark and Thomas, Robert and Tsunoda, Audrey T. and van de Velde, Cornelis and Veronesi, Umberto and Vijaykumar, Dehannathparambil Kottarathil and Watters, David and Wang, Shan and Wu, Yi-Long and Zeiton, Moez and Purushotham, Arnie},
  issn         = {1474-5488},
  language     = {eng},
  number       = {11},
  pages        = {1193--1224},
  publisher    = {Elsevier},
  series       = {The Lancet Oncology},
  title        = {Global cancer surgery: delivering safe, affordable, and timely cancer surgery},
  url          = {http://dx.doi.org/10.1016/S1470-2045(15)00223-5},
  volume       = {16},
  year         = {2015},
}